Home > Cashflow Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cashflow Statement

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Profit Before Tax₹42 Cr₹36 Cr₹-63 Cr₹12 Cr-
Adjustment ₹10 Cr₹13 Cr₹102 Cr₹8.18 Cr-
Changes In working Capital ₹23 Cr₹-9.81 Cr₹-19 Cr₹-5.72 Cr-
Cash Flow after changes in Working Capital ₹75 Cr₹39 Cr₹20 Cr₹15 Cr-
Cash Flow from Operating Activities ₹75 Cr₹38 Cr₹17 Cr₹14 Cr-
Cash Flow from Investing Activities ₹-27 Cr₹-2.88 Cr₹-20 Cr₹-21 Cr-
Cash Flow from Financing Activities ₹-7.78 Cr₹-1.67 Cr₹-22 Cr₹5.74 Cr-
Net Cash Inflow / Outflow ₹39 Cr₹34 Cr₹-25 Cr₹-0.81 Cr-
Opening Cash & Cash Equivalents ₹38 Cr₹4.18 Cr₹29 Cr₹3.29 Cr-
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹77 Cr₹38 Cr₹4.18 Cr₹2.48 Cr-

Compare Cashflow Statement of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹286.3 Cr -6.4% -10.1% -25% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,592.2 Cr -9.5% -21.2% -0.4% Stock Analytics
KAVERI SEED COMPANY ₹5,148.0 Cr 2.1% 11% 55.9% Stock Analytics
VENKYS (INDIA) ₹2,301.8 Cr -1.3% -9.9% -9.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,405.4 Cr -7% -12.6% -38.5% Stock Analytics
INDO US BIOTECH ₹394.8 Cr -9.8% -10.3% -14.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-6.4%

-10.1%

-25%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses